We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites 22 Failed Trials in Report, Making the Case for the Phase III Gold Standard
FDA Cites 22 Failed Trials in Report, Making the Case for the Phase III Gold Standard
The FDA compiled 22 case studies of different drugs, vaccines and devices that demonstrated promising results in Phase II studies, but later failed in larger Phase III clinical trials.